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Chapter 2
Pathogenesis
Abstract In this section the different phases of infection with Mycobacterium
tuberculosis will be reviewed. Starting from transmission by inhalation, to the
innate and adaptive immune response and the dual role of tuberculoma formation in
walling off infection, but also providing an advantageous environment for bacilli to
survive and multiply. Recent data has shown the role of Tumour Necrosis Factor
alpha (TNF-α) in tuberculoma maintenance and its genetic control is more complex
than previously thought. The role of vitamin D in susceptibility to tuberculosis also
an area which has seen a resurgence of interest and new evidence emerging that
targeted vitamin D therapy may have a role in improving TB outcomes.
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2.1 Transmission
Transmission of TB is by inhalation of infectious droplet nuclei containing viable
bacilli (aerosol spread). Mycobacteria-laden droplet nuclei are formed when a
patient with active pulmonary TB coughs and can remain suspended in the air for
several hours. Sneezing or singing may also expel bacilli. Factors influencing the
chance of transmission include the bacillary load of the source case (sputum
smear-positive or lung cavities on chest radiograph), as well as the proximity and
duration of exposure (Escombe et al. 2008). Transmission is dramatically and
rapidly reduced with effective treatment (Dharmadhikari et al. 2014). In general, the
risk of infection among household contacts of TB patients is *30 % (Singh et al.
2005) (Fig. 2.1).
For reasons not clearly understood, the majority of individuals infected with
M. tuberculosis (*90 %) do not develop disease. Following inhalation of
M. tuberculosis an individual may have one of the following outcomes: (1) fail to
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register an infection, (2) become infected but then clear the infection, (3) success-
fully contain the infection but continue to harbour bacilli in the absence of
symptomatic disease (latent TB infection), or (4) develop progressive TB disease
(Saenz et al. 2013). It has been estimated that one-third of the world population
have latent TB infection and may be at risk to develop TB disease as they age, or
become immunocompromised in the future. The factors resulting in reactivation of
latent TB infection in the absence of overt immune suppression are not well
understood, but the huge reservoir of individuals with latent TB infection represents
a major barrier to TB elimination (Dye and Williams 2010).
Susceptibility to TB is influenced by environmental, host and pathogen factors.
Innate immune responses play a crucial role in host defense against mycobacteria
(Fig. 2.2). Although numerous gene polymorphisms have been identiﬁed which
influence host susceptibility to TB, it is apparent that in the vast majority of cases
susceptibility is polygenetic (Fitness et al. 2004). The complex interplay of multiple
genetic variants has yet to be fully elucidated. On-going genome wide association
studies (GWAS) studies should better illuminate genetic determinants of TB sus-
ceptibility and disease severity (O’Garra et al. 2013). In children immune maturation
is a major determinant of risk with infants (<2 years of age) being at highest risk of
disease development and potential dissemination (Perez-Velez and Marais 2012).
2.2 The Innate Immune Response
The key players in the innate defence against M. tuberculosis are the alveolar
macrophages and dendritic cells. Macrophages, dendritic cells and other immune
cells recognize mycobacterial structures, pathogen associated molecular patterns
(PAMPs) with membrane associated pattern recognition receptors (PRRs), of which
the most studied are the Toll-like receptors (TLR2, TLR4, TLR9). PAMPs such as
lipoarabinomannan, phosphatidylinositol and heat shock proteins (Hsp65 and
Hsp70), and mycobacterial nucleic acids, such as the CpG motif, are recognized by
TLRs. On interaction with the TLRs, signalling pathways are activated which lead
to the production of predominantly proinflammatory cytokines, such as TNF,
IL-1B, IL-12 and nitric oxide (Kleinnijenhuis et al. 2009; van Crevel et al. 2002).
Fig. 2.1 Transmission of TB
bacilli. Source CDC
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PRR-mediated phagocytosis of the pathogen by macrophages is an essential
feature of the innate immune response. Ingested bacteria are then destroyed through
phagosome-lysosome fusion and acidiﬁcation (by H2O2 and other reactive oxygen
intermediates) however M. tuberculosis may subvert this process and evade
Fig. 2.2 Host genotype influences response to treatment with adjunctive steroids in Vietnamese
patients with TB meningitis. A Humans may have polymorphisms in the LTA4H gene locus,
which influence the severity of the inflammatory response. A process which is thought to be
analogous to the susceptibility of zebraﬁsh to Mycobacterium marinum infection. B Patients with
the TT (high inflammatory) genotype, respond well to adjunctive treatment with dexamethasone.
From Tobin et al., Cell, 2012, reprinted with permission
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destruction (Sullivan et al. 2012). Essentially the innate immune response mediated
through macrophages can have three major results; (1) cell necrosis, (2) apoptosis
(3) survival of the infected macrophages. If the cell undergoes necrosis, myco-
bacteria are released and may infect new macrophages or disseminate whereas an
apoptotic cell membrane is not compromised and the bacteria are destroyed with the
macrophage. Survival of infected macrophages enables the mycobacteria to persist
and even proliferate before the adaptive immune response is activated by speciﬁc
T-cells that have been selected in the regional lymph nodes; generally 2–3 weeks
after primary infection (Saenz et al. 2013).
2.3 The Adaptive Immune Reponse
Dendritic cells are an important mediator between the innate and adaptive immune
response which in addition to phagocytosis, present live mycobacteria to naïve
T cells after migrating to regional lymph nodes. After antigen presentation in lymph
nodes, CD4+ T cells are activated, and migrate to the lungs to impede mycobac-
terial progressive growth. The crucial role of T-cells in immunity to mycobacteria is
evidenced by the dramatically increased susceptibility of individuals with HIV
infection. Susceptibility to TB increases as the CD4 cell count decreases. IFN-γ,
produced by activated T-cells, has a crucial role in protection against TB.
IFN-knock-out mice, and humans with impaired IFN-γ genes are highly susceptible
to severe TB disease (van Crevel et al. 2002). IFN-γ is essential in macrophage
activation and intracellular mycobacterial killing (Flynn et al. 1993). TNF-α is
another key cytokine produced by macrophages, dendritic cells and T cells and
plays a central role in granuloma formation, macrophage induction and has
immunoregulatory properties. Patients using TNF suppressing agent are at
increased risk of infection and reactivation. A Cochrane review of TNF-α inhibitors
given for any indication found a summary risk estimate odds ratio [OR] of 4.68,
[95 %CI: 1.18–18.60] for reactivation of TB compared to control groups (Singh
et al. 2011). However, TNF may also contribute to deleterious inflammatory
responses in patients with progressive disease.
2.4 The Complex Role of TNF and Its Genetic Control
Although it is observed that TNF suppression can cause more rapid progression to
TB disease, many aspects of the diverse functions of this proinflammatory factor
have yet to be elucidated (Souto et al. 2014; Murdaca et al. 2015). Currently it is
proposed that the effect of TNF on containment of mycobacterial infection is
achieved by mediating the maintenance of granuloma integrity by regulating
cell-adhesion proteins, chemokine attraction, and preventing T-cell dependent
granuloma disintegration and inflammatory destruction by regulating IFN
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producing CD4+ and CD8+ T cells. A second mechanism is by promoting apop-
tosis of mycobacteria containing macrophages, rather than non-apoptotic death,
thus preventing intercellular spread of bacteria (Miller and Ernst 2008).
It has been shown that in a Vietnamese population with TB meningitis that a
polymorphism in the LTA4H gene which leads to either excessive or deﬁcient
TNF-α production can determine the response to adjunctive dexamethasone ther-
apy. This polymorphism was initially identiﬁed in a zebraﬁsh model of myco-
bacterial infection (Cronan and Tobin 2014). TB meningitis patients with an
excessive TNF-α genotype appeared to beneﬁt from adjunctive corticosteroids, with
decreased mortality. While for those with a low TNF-genotype, steroids may
actually be harmful, with increased mortality observed in this group when receiving
steroids. It is possible that similar naturally occurring variants in the LTA4H
genotype in all individuals exposed to TB may influence susceptibility and disease
progression. It is now becoming apparent that rather than a simplistic model of high
pro-inflammatory response being protective, the most protective response is bal-
anced between pro-and anti-inflammatory mediators, or ‘just right’, which has led
to the term ‘Goldilocks’ gene (Tobin et al. 2013).
2.5 The Tuberculoma
The hallmark of mycobacterial infection is the tuberculoma or granuloma. Our
current knowledge on granuloma development in the human in the different stages
of disease stems from meticulous post-mortem studies performed more than a
century ago. Granulomas are described by gross pathological appearance: solid or
non-necrotic, caseous or necrotic, or end-stage cavitary. Depending on the degree of
liquefaction, the caseum (from Latin, cheese-like), can be referred to as liquid/soft
or solid/hard. It is thought that in solid necrosis, the mycobacteria are more efﬁ-
ciently contained, and generally less viable mycobacterium are found in hard ca-
seum. If sufﬁciently large, the granulomas may drain their (liquid) content into the
bronchial tree, releasing viable bacilli into the airways, to be aspirated into other
parts of the lung or coughed up and transmitted. If associated with parenchymal
destruction it heralds the onset of lung cavities, where extra-cellular bacilli multiply
exponentially. It has long been assumed that the granuloma formation serves the
host in containing the bacilli and preventing bacterial spread but it may also be
exploited by the bacilli to proliferate (Ramakrishnan 2012). Indeed many people
have evidence of healed granulomas, without having experienced active tubercu-
lous disease. However, it is evident that control of infection within granulomas are
not necessarily homogeneous within the same individual and ineffective in a sub-
stantial proportion of the global population.
On microscopic level the tuberculous granuloma is an organized aggregation of
immune cells and debris. It contains macrophages that have undergone morpho-
logical change into epithelioid cells which form into zipper-like arrays around the
necrotic centre. They retain the ability to phagocytise mycobacteria. Macrophages
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can also fuse to form multinucleated giant cells and foam cells, which have high
lipid contents, but only few bacteria and their protective role is uncertain. Other cell
types surrounding the granuloma are dendritic cells, neutrophils, B cells, T cells,
natural killer (NK) cells, ﬁbroblasts. Epithelial cells often are found in the outer
layer of the granuloma. Mycobacteria are concentrated in the periphery of the
central necrotic area.
2.6 Vitamin D and the Immune Response
In the pre-antibiotic era TB patients were often treated with cod-liver oil and
sunshine, both sources of 25-hydroxyvitamin-D, which has immunomodulatory
properties. Currently the interest in the role of vitamin D-status in susceptibility to
TB and the use of vitamin D adjunctive to antimycobacterial treatment has been
re-ignited (Nunn et al. 2013). Particularly in the context of multi drug resistance,
adjunctive treatment with vitamin D may be of importance in TB patients as,
second-line treatment regimens are less bactericidal and should be paired with an
optimal immune response in order to effectively eliminate infection.
2.6.1 Vitamin D Metabolism
Vitamin D is historically associated with bone disease for its role in maintenance of
calcium homeostasis by promoting calcium absorption in the intestines and bone
resorption, processes which are regulated by parathyroid hormone. However, the
anti-inflammatory properties of vitamin D are increasingly being investigated by
researchers globally in the context of other conditions, such as diabetes, infectious
and autoimmune diseases and cardiovascular disease (Theodoratou et al. 2014).
Dietary sources of vitamin D are limited, however ﬁsh liver oils and fatty ﬁsh
naturally contain vitamin D. It is difﬁcult however to get the acquired intake of
vitamin D solely from natural dietary sources. Sunlight is a another source of
Vitamin D, as after exposure to ultraviolet B, 7-dehydrocholesterol in the plasma
membrane of human keratinocytes is converted to previtamin D3, from which
vitamin D3 (cholecalciferol) is formed. Vitamin D is fat soluble and is carried in the
circulation by hepatically produced vitamin D-binding protein. In the liver, vitamin
D is hydroxylated to form 25-hydroxyvitamin (25(OH)D) (also known as calcidiol,
the serum measure of vitamin D), which is converted to the steroid hormone
1,25-dihydroxyvitamin D (calcitriol, the biologically active metabolite) in the
kidneys. The actions of the hormone are mediated either through ligation with a
nuclear vitamin D-receptor (VDR) to regulate gene transcription, resulting in
genomic responses, or via membrane rapid-response receptors (Ralph et al. 2013;
Coussens et al. 2014).
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2.6.2 Antimicrobial Effects of Vitamin D
Several mechanisms are proposed by which vitamin D may exert antimycobacterial
properties and enhances the immune response. In particular the transcription of
cathelecidin is completely dependant on sufﬁcient levels of 1,25-hydroxyvitamin D
(Aranow 2011). Cathelecidin destroys microbial membranes in the phagolysosome
in macrophages.
2.6.3 Vitamin D Deﬁciency and Susceptibility
to Tuberculosis
Vitamin D deﬁciency has been implicated to play a role in increased susceptibility
to active TB disease in numerous studies.
25-hydroxyvitamin-D receptors are present on all immune cells, including
macrophages, and are upregulated after stimulation of Toll-like receptors, which
play a central role in mycobacterial recognition. Polymorphisms in the VDR
receptor potentially modulate the activity of the receptor and thus the action of
Vitamin D. A meta-analysis of the most widely studied polymorphisms in the VDR
(FokI, TaqI, ApaIand BsmI) and susceptibility to TB, showed that among Asians,
the FokIff genotype had a positive association (OR 2.0, 95 %CI 1.3–3.2) with TB,
whereas, a signiﬁcant inverse association was observed for the BsmI bb genotype
(OR 0.5, 95 %CI 0.4–0.8). Marginal signiﬁcant associations were found for TaqI
and ApaI polymorphisms (Gao et al. 2010).
A meta analysis of 7 studies on vitamin D status and susceptibility to TB,
including 531 individuals found that patients with tuberculosis have lower average
pre-treatment serum levels of vitamin D than healthy controls matched on sex, age,
ethnicity, diet and geographical location. The pooled effect size in random effects
meta-analysis was 0.68 (95 %CI 0.43–0.93) (Nnoaham and Clarke 2008).
A systematic Cochrane review in 2011 found no consistent evidence of bene-
ﬁcial impact on TB treatment outcomes for micronutrient supplementation,
including vitamin D (Sinclair et al. 2011). Supplementation of patients on treatment
for pulmonary TB has been associated with accelerated resolution of inflammatory
responses (Coussens et al. 2012). Supplementation led to accelerated clinical and
radiological recovery as well as an enhanced immune response in those with
deﬁcient serum vitamin D at diagnosis in a recent trial (Salahuddin et al. 2013)
(Fig. 2.3).
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Fig. 2.3 Schematic representation of basic immunological antimycobacterial mechanisms in the
lung and lymphnode. Macrophages and dendritic cells initially encounter Mycobacterium
tuberculosis (M.TB) in the lung. A After ingestion, macrophages can undergo apoptosis or
necrosis. After necrosis, bacterial spread may ensue. Surviving macrophages assist in early
granuloma formation, either leading to elimination or clinical latency. B The mycobacteria can
evade the immune response by inhibiting phagolysosome formation and apoptosis, as well as
blocking the response of macrophages to IFNγ. C Resident dendritic cells of the lung can travel to
regional lymphnodes, presenting live mycobacteria and mycobacterial antigen, activating naïve
T-cells, B-cells and regulatory T-cells. D In the lung, activated T-cells and B-cells (attracted to the
lung by chemokines) control bacterial growth by production of cytokines and antibodies.
Regulatory T-cells control the inflammation through the production of IL-10 and TGF-β. Adapted
from Saenz et al. Tuberculosis, 2013, adapted and reprinted with permission
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